Clinical trial NCT06261502
Status: RecruitingPhase 2Latest change: Source: ClinicalTrials.gov
What's on this page?
Information in the record
Original title: Effect of CANnabidiol on Anxiety and GABAergic Function in Individuals With Fragile-X Syndrome
- Record number
- NCT06261502
- Status
- Recruiting
- Type and phase
- Clinical trial, phase 2
- Participants
- Target: 40
- Condition (as registered)
- Fragile X Syndrome
- Countries
- Canada
- Topic in the guide
- Anxiety
Timeline
According to the ClinicalTrials.gov record. Future dates are the investigator’s estimates and may change.
- Start: September 1, 2025
- End of data collection for primary results: July 1, 2028 (expected)
- Trial completion: December 1, 2028 (expected)
History
We check the record every day; here are the changes we have seen since we started tracking it, newest first.
- : Added to tracking. Status: Recruiting.
Results
No results have been published yet. When they are, they will appear here. A trial being under way does not mean CBD works for this condition; only the results can show that.
All ongoing trials · Anxiety: ongoing trials · Thinking of taking part? Which specialist to see